PMH13 ESTIMATING THE BENEFIT OF LONG-ACTING INJECTABLES FOR SCHIZOPHRENIA TREATMENT IN RWANDA USING A ONE-YEAR COST-CONSEQUENCE MODEL
| Autor: | Thomas, T., Keenan, A., Ngirababyeyi, A., Mwaniki, K., Iyamuremye, J.D., Smith-Swintosky, V., Abraham, E., Kayiteshonga, Y., Rutakayire, B., Kanyandekwe, S. |
|---|---|
| Zdroj: | In Value in Health May 2019 22 Supplement 2:S227-S227 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect